Borneol-Shellac Nanofiber Membranes Fabricated Using a Modified Coaxial Electrospinning

Article Preview

Abstract:

A modified coaxial electrospinning process is developed for producing medicated nanofiber membranes of shellac. With pure ethanol as a sheath fluid, high quality borneol-loaded shellac nanofibers have been successfully fabricated using the modified coaxial process. Electron scanning microscopic observations demonstrated that the nanofibers had better quality than those fabricated using a single fluid electrospinning in terms of nanofiber diameters and their distributions. The former had an average diameter of 570 ± 80 nm under a sheath-to-core flow rate ratio of 0.25, whereas the later was 940 ± 230 nm. X-ray diffraction results verified that borneol existed in the shellac matrix in an amorphous state. The medicated nanofiber membranes could significantly improved the physical stability of borneol due to the favorable hydrogen bonding between the drug and the polymer matrix, as demonstrated by the weight loss experiments. The modified coaxial electrospinning process described here expands the capability of electrospinning process in generating high quality functional membranes.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

78-82

Citation:

Online since:

November 2014

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2014 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] S. Agarwal, A. Greiner, and JH Wendorff, Prog. Polym. Sci. 38 (2013) 963-991.

Google Scholar

[2] D. G. Yu, G. R. Williams, X. Wang, X. K. Liu, H. L. Li, and S. W. A. Bligh, RSC Adv. 3 (2013) 4652-4658.

Google Scholar

[3] D. G. Yu, Y. Liao, X. Li, W. Chian, Y. Li, and X. Wang, J. Control. Release 172 (2013) e14-e97.

Google Scholar

[4] D. G. Yu, X. Wang, X. Y. Li, W. Chian, Y. Li, and Y. Z. Liao, Acta Biomater. 9 (2013) 5665-5672.

Google Scholar

[5] S. Limmatvapirat, D. Panchapornpon, C. Limmatvapirat, J. Nunthanid, M. Luangtana-Anan, and S. Puttipipatkhachorn S, Eur. J. Pharm. Biopharm. 70 (2008) 335-344.

DOI: 10.1016/j.ejpb.2008.03.002

Google Scholar

[6] X. Y. Li, X. Wang, D. G. Yu, S. Ye, Q. K. Kuang, Q. W. Yi, and X. Z. Yao, J. Nanomater. 2012 (2012), Doi: 10. 1155/2012/731382.

Google Scholar

[7] T. Loftsson, and M. E. Brewster, J. Pharm. Sci. 85 (1996) 1017-1025.

Google Scholar